Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TransMedics (TMDX) Long-Term Deferred Tax (2025)

TransMedics has reported Long-Term Deferred Tax over the past 1 years, most recently at $83.5 million for Q4 2025.

  • Quarterly results put Long-Term Deferred Tax at $83.5 million for Q4 2025, changed N/A from a year ago — trailing twelve months through Dec 2025 was $83.5 million (changed N/A YoY), and the annual figure for FY2025 was $83.5 million, changed.
  • Long-Term Deferred Tax for Q4 2025 was $83.5 million at TransMedics.
  • Over the last five years, Long-Term Deferred Tax for TMDX hit a ceiling of $83.5 million in Q4 2025 and a floor of $83.5 million in Q4 2025.